Skip to main content
Journal cover image

Impact of inhibitory and activating KIR and HLA ligands in non-myeloablative haplo hematopoietic transplants in patients with high-risk lymphoid malignancy

Publication ,  Conference
Prasad, V; Chen, D; Broadwater, G; Reinsmoen, N; Clark, A; Chao, N; Rizzieri, D
Published in: TISSUE ANTIGENS
2008

Duke Scholars

Published In

TISSUE ANTIGENS

ISSN

0001-2815

Publication Date

2008

Volume

72

Issue

3

Start / End Page

302 / 302

Related Subject Headings

  • Immunology
  • 3204 Immunology
  • 3105 Genetics
  • 1107 Immunology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Prasad, V., Chen, D., Broadwater, G., Reinsmoen, N., Clark, A., Chao, N., & Rizzieri, D. (2008). Impact of inhibitory and activating KIR and HLA ligands in non-myeloablative haplo hematopoietic transplants in patients with high-risk lymphoid malignancy. In TISSUE ANTIGENS (Vol. 72, pp. 302–302).
Prasad, V., D. Chen, G. Broadwater, N. Reinsmoen, A. Clark, N. Chao, and D. Rizzieri. “Impact of inhibitory and activating KIR and HLA ligands in non-myeloablative haplo hematopoietic transplants in patients with high-risk lymphoid malignancy.” In TISSUE ANTIGENS, 72:302–302, 2008.
Prasad V, Chen D, Broadwater G, Reinsmoen N, Clark A, Chao N, et al. Impact of inhibitory and activating KIR and HLA ligands in non-myeloablative haplo hematopoietic transplants in patients with high-risk lymphoid malignancy. In: TISSUE ANTIGENS. 2008. p. 302–302.
Prasad V, Chen D, Broadwater G, Reinsmoen N, Clark A, Chao N, Rizzieri D. Impact of inhibitory and activating KIR and HLA ligands in non-myeloablative haplo hematopoietic transplants in patients with high-risk lymphoid malignancy. TISSUE ANTIGENS. 2008. p. 302–302.
Journal cover image

Published In

TISSUE ANTIGENS

ISSN

0001-2815

Publication Date

2008

Volume

72

Issue

3

Start / End Page

302 / 302

Related Subject Headings

  • Immunology
  • 3204 Immunology
  • 3105 Genetics
  • 1107 Immunology
  • 1103 Clinical Sciences